The START Center for Cancer Research (“START”) is the world’s largest early phase site network, fully dedicated to oncology clinical research. Throughout our history, START has provided hope to cancer patients in global community practices by offering access to cutting edge trials throughout the US and Europe. Today, with over 1,300 studies completed, and with research facilities in the United States and in Spain, Portugal, and Ireland, START’s mission is to accelerate the development of new anticancer drugs that will improve the quality of life and survival for patients with cancer and lead to its eventual cure. To date, over 43 therapies conducted at START locations have obtained FDA/EMA approval. Incredibly, while Academic Medical Centers (AMCs) conduct 80% of cancer trials, such trials reach only 20% of the patient population – leaving the majority of patients who are treated in community practices and hospitals without access to a clinical trial when their care journey calls for one. START serves the many – by bringing cancer trials to physicians and their patients in community hospitals and practices when hope is needed most.
START represents the world’s largest roster of Principal Investigators (PIs) across its eight clinical trial sites. Committed to accelerating passage from trials to treatments, START delivers hope to patients, families, and physicians around the world. As an example, in San Antonio, where START was founded, START treated the first patient ever with Keytruda – the most effective cancer drug in medical history.
Essential Responsibilities
Education & Experience
Physical & Travel Requirements:
Best-in-Class Benefits and Perks
We value our employees’ time and efforts. Our commitment to your success is enhanced by a competitive compensation, depending on experience, and an extensive benefits package including:
More about The START Center for Cancer Research
Deeply rooted in community oncology centers globally, The START Center for Cancer Research provides access to specialized preclinical and early-phase clinical trials of novel anti-cancer agents. START clinical trial sites have conducted more than a thousand early-phase clinical trials, including for 43 therapies that were approved by the FDA. START represents the world’s largest roster of Principal Investigators (PIs) across its eight clinical trial sites. Committed to accelerating passage from trials to treatments, START delivers hope to patients, families, and physicians around the world. Learn more at STARTresearch.com .
Burns Dirt - Columbus, Mississippi Burns Group is a family-owned business, established in 1977 serving the civil construction and aggregates industry in the Southeast. Our portfolio includes heavy civil, logistics, and recycling divisions. Our core values and dedication...
...construction, agricultural, or other off-highway equipment domains. Knowledge of CAN, J1939, or other vehicle communication protocols. Exposure to model-based development tools (MATLAB/Simulink). Experience working in Agile or V-model development environments....
...looking for an L2 Client Support Engineer with MSP experience who enjoys working directly with clients and taking ownership of issues from first response through resolution. This is a hybrid work from home role based in Boston. You will split time between remote support...
...may require additional in-office workdays. About The Role The Trust & Safety team at Notion is looking for a full-time Fraud & Abuse Analyst to join our operational account security team. As a Fraud & Abuse Analyst, youll work closely with our engineers & business...
...Position Overview Plateau Excavation is seeking a BIM Engineer to support the planning, coordination, and execution of large-scale sitework, infrastructure, and mission-critical projects across the Southeast. Reporting to the BIM Manager , this role focuses on developing...